No Data
No Data
Does Adient (NYSE:ADNT) Have A Healthy Balance Sheet?
Wells Fargo Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $29
Morgan Stanley Maintains Adient(ADNT.US) With Sell Rating, Maintains Target Price $21
Adient Is Maintained at Underweight by Morgan Stanley
What Analysts Are Saying About Adient Stock
Morgan Stanley Maintains Adient(ADNT.US) With Sell Rating, Cuts Target Price to $21
I Am 102927471 :![](https://emoticon.futunn.com/moomoo_winter_day/mw_05.png)